| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A systematic review of survival following anti-cancer treatment for small cell lung cancer
|
Jones, Gavin S.
|
|
|
141 |
C |
p. 44-55
|
artikel
|
| 2 |
Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer
|
Ebert, Eva Boysen Fynboe
|
|
|
141 |
C |
p. 37-43
|
artikel
|
| 3 |
Contents
|
|
|
|
141 |
C |
p. v-vi
|
artikel
|
| 4 |
COPD and lung cancer incidence in the Women’s Health Initiative Observational Study: A brief report
|
Nagasaka, Misako
|
|
|
141 |
C |
p. 78-81
|
artikel
|
| 5 |
Corrigendum to “Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosis” [Lung Cancer 68 (1) (2010) 27–38]
|
Zhuang, Hongqin
|
|
|
141 |
C |
p. 119-120
|
artikel
|
| 6 |
Cost-effectiveness of stereotactic body radiation therapy versus video assisted thoracic surgery in medically operable stage I non-small cell lung cancer: A modeling study
|
Wolff, Henri B.
|
|
|
141 |
C |
p. 89-96
|
artikel
|
| 7 |
Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer
|
Haentschel, Maik
|
|
|
141 |
C |
p. 56-63
|
artikel
|
| 8 |
Cytology for PD-L1 testing: A systematic review
|
Gosney, John R.
|
|
|
141 |
C |
p. 101-106
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
141 |
C |
p. iii
|
artikel
|
| 10 |
Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer
|
Yoshimura, Katsuhiro
|
|
|
141 |
C |
p. 21-31
|
artikel
|
| 11 |
Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world population
|
Zeng, Liang
|
|
|
141 |
C |
p. 82-88
|
artikel
|
| 12 |
Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery
|
Li, Changhui
|
|
|
141 |
C |
p. 72-77
|
artikel
|
| 13 |
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer
|
Rice, Shawn J.
|
|
|
141 |
C |
p. 97-100
|
artikel
|
| 14 |
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib
|
Zhao, Jun
|
|
|
141 |
C |
p. 114-118
|
artikel
|
| 15 |
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer
|
van Veggel, B.
|
|
|
141 |
C |
p. 9-13
|
artikel
|
| 16 |
Positive EGFR mutation status is a risk of recurrence in pN0–1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis
|
Ito, Masaoki
|
|
|
141 |
C |
p. 107-113
|
artikel
|
| 17 |
Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer
|
Cao, Xiaowen
|
|
|
141 |
C |
p. 14-20
|
artikel
|
| 18 |
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent
|
Buglione, Michela
|
|
|
141 |
C |
p. 1-8
|
artikel
|
| 19 |
Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study
|
Niho, Seiji
|
|
|
141 |
C |
p. 64-71
|
artikel
|
| 20 |
Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503
|
Kubota, Kaoru
|
|
|
141 |
C |
p. 32-36
|
artikel
|
Tijdschrift beschrijving